参考文献/References:
[1]HAESEBROUCK F, CHIERS K, VAN OVERBEKE I, et al. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection [J]. Vet Microbiol,1997,58(2/3/4):239-249.
[2]BOSS J T, JANSON H, SHEEHAN B J, et al. Actinobacillus pleuropneumoniae:pathobiology and pathogenesis of infection[J]. Microbes Infect,2002,4(2):225-235.
[3]郭志英,李郁,吴浩阳. 猪胸膜肺炎放线杆菌的分离鉴定及其生物学特性的研究[J]. 中国兽医科学,2016,46(9): 1102-1109.
[4]FREY J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins[J]. Trends Microbiol,1995,3(7):257-261.
[5]CHIERS K, DE WAELE T, PASMANS F, et al. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host[J]. Veterinary Research,2010,41(5):65.
[6]BROGAARD L, KLITGAARD K, HEEGAARD P M H, et al. Concurrent host-pathogen gene expression in the lungs of pigs challenged with Actinobacillus pleuropneumoniae[J]. BMC Genomics,2015,16(1):15.
[7]CHIANG C H, HUANG W F, HUANG L P, et al. Immunogenicity and protective efficacy of ApxⅠA and ApxⅡA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model[J]. Vaccine,2009,27(34):4565-4570.
[8]SEO K W, KIM D H, KIM A H, et al. Characterization of antigenic determinants in ApxⅡA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge[J]. Immunological Investigations,2011,40(5):465-480.
[9]TO H, NAGAI S, IWATA A, et al. Genetic and antigenic characteristics of ApxⅡA and ApxⅢA from Actinobacillus pleuropneumoniae serovars 2, 3, 4, 6, 8 and 15[J]. Microbiology and Immunology,2016,60(7):447-458.
[10]LOERA-MURO A, ANGULO C. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae[J]. Veterinary Microbiology,2018,217:66-75.
[11]WANG C L, WANG Y, SHAO M L, et al. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae[J]. Vaccine,2009,27(42):5816-5821.
[12]NAKAYAMA Y. Corynebacterium glutamicum mechanosensing: from osmoregulation to l-glutamate secretion for the avian microbiota-gut-brain axis[J]. Microorganisms,2021,9(1):201.
[13]徐美娟,上官春雨,陈鑫,等. 谷氨酸棒杆菌耐受胁迫机制及工业鲁棒性合成生物学研究进展[J]. 生物工程学报,2021,37(3):831-845.
[14]董贵彬,潘颖越,司雅楠,等. 人胃内因子在谷氨酸棒杆菌中的表达及活性研究[J]. 生物学杂志,2020,37(2):5-9.
[15] HAYAT S M G, FARAHANI N, GOLICHENARI B, et al. Recombinant pro-tein expression in Escherichia coli (E.coli):what we need to know[J]. Current Pharmaceutical Design, 2018,24(6):718-725.
[16]孙曼曼,高雄,方求武,等. 谷氨酸棒杆菌增强型表达载体构建及牛α-干扰素表达[J]. 生物学杂志,2020,37(3):16-20.
[17] LIU X X, ZHANG W, ZHAO Z H, et al. Protein secretion in Corynebacterium glutamicum[J]. Critical Reviews in Biotechnology,2017,37(4):541-551.
[18] LIU X X, MENG L H, WANG X Y, et al. Effect of Clp protease from Corynebacterium glutamicum on heterologous protein expression[J]. Protein Expression and Purification,2021,189:105928.